Sunshine Biopharma Inc. Deposits Assets, Current
Sunshine Biopharma Inc. (SBFM) had Deposits Assets, Current of $70.46 thousand as of 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:DepositsAssetsCurrent · last filed 2025-05-15
- 2025-03-31: Deposits Assets, Current $70.46K.
- 2024-12-31: Deposits Assets, Current $0.00.
- 2022-12-31: Deposits Assets, Current $0.00.
- 2022-09-30: Deposits Assets, Current $7.59K.
| Period end | Deposits Assets, Current |
|---|---|
| 2025-03-31 | $70.46K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $0.00 10-Q · filed 2025-05-15 |
| 2022-12-31 | $0.00 10-K · filed 2023-04-04 |
| 2022-09-30 | $7.59K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $7.59K 10-Q · filed 2022-08-03 |
| 2022-03-31 | $7.59K 10-Q · filed 2022-05-06 |
| 2021-12-31 | $7.59K 10-K · filed 2023-04-04 |
| 2021-09-30 | $7.59K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $7.59K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $7.59K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $7.59K 10-K · filed 2022-03-21 |
| 2020-09-30 | $7.59K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $7.59K 10-Q/A · filed 2020-08-31 |
| 2020-03-31 | $7.59K 10-Q · filed 2020-05-18 |
| 2019-12-31 | $7.59K 10-Q · filed 2020-11-12 |
| 2019-09-30 | $7.59K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $7.59K 10-Q · filed 2019-08-15 |
| 2018-12-31 | $0.00 10-Q · filed 2019-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |